The conference call will focus on, amongst other u
Post# of 148175
Quote:
The conference call will focus on, amongst other updates, the following key agenda items:
Status of filing the Biologics License Application (BLA) for leronlimab in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients
Update on CytoDyn’s therapeutic indications involving cancer
Update on potential use of leronlimab in China to treat the 2019 Novel Coronavirus (2019-nCov)
Looks like its the first item of discussion